Increased Scanning with CGM Improves Glucose Control in T1D
Drug Topics
OCTOBER 31, 2022
Research shows that an increase in intermittent scanning helps improve glycemic control and reduce the fear of hypoglycemia.
Mon.Oct 31, 2022
428 
Tips for tackling trial recruitment and retention woes in oncology
PharmaVoice
OCTOBER 31, 2022
How new tools are helping companies find and keep cancer patients in clinical studies.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Examining the Safety and Efficacy of Oral Zinc and Low-Dose Isotretinoin for Acne Vulgaris
Drug Topics
OCTOBER 31, 2022
Numerous adverse effects are associated with standard-dose isotretinoin.
Protecting treatment advances for National Breast Cancer Awareness Month
PhRMA
OCTOBER 31, 2022
Since the 1980s, October has been recognized as National Breast Cancer Awareness Month — an opportunity for us to unite as a community to honor those who have had breast cancer and raise awareness about progress biopharmaceutical researchers have made towards treating the disease.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
October Month in Review: Top Stories on Drug Topics®
Drug Topics
OCTOBER 31, 2022
Take a look back at our most popular news from October 2022.
How does the Inflation Reduction Act affect healthcare?
PharmaVoice
OCTOBER 31, 2022
The Inflation Reduction Act helps support American families by lowering prescription drug prices and reducing overall healthcare costs.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Wearables Made for the Pharmaceutical Industry
Pharmacy Times
OCTOBER 31, 2022
Purpose-built assisted reality solutions help streamline processes and maintain regulatory compliance from the laboratory to the factory floor.
Advanced Point of Sale Functional Testing
Drug Topics
OCTOBER 31, 2022
Hillary Howell, PharmD, FACA, CNN talks point of sale functional testing at the October 2022 Total Pharmacy Solutions Summit.
If You Want to Know Where Pharmacists' Roles Are Heading, Follow Patients
Pharmacy Times
OCTOBER 31, 2022
Last year in particular, pharmacists played a greater role in patient care with an increased workload as they connected patients, providers, and payers.
Total Pharmacy Solutions Summit CE Sessions Available On Demand at AdvanCE
Drug Topics
OCTOBER 31, 2022
CE sessions from the Total Pharmacy Solutions Summit are now on demand.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Verge Genomics takes AI-sourced drug for ALS into clinic
pharmaphorum
OCTOBER 31, 2022
Verge Genomics has joined a select group of biotechs who have taken a drug discovered and developed using artificial intelligence into human testing. The small-molecule PIKfyve inhibitor – called VRG50635 – has been administered to the first subject in the phase 1 trial involving healthy volunteers, according to the San Francisco-based biotech, which was founded in 2015 by Alice Zhang and Jason Chen.
Protecting treatment advances for breast cancer
PhRMA
OCTOBER 31, 2022
Since the 1980s, October has been recognized as National Breast Cancer Awareness Month — an opportunity for us to unite as a community to honor those who have had breast cancer and raise awareness about progress biopharmaceutical researchers have made towards treating the disease.
Vaccine chief’s exit spurs new slate of GSK executive changes
PharmaVoice
OCTOBER 31, 2022
How the pharma giant is consolidating power as it looks to become a dominant force in the vaccine market.
Clinical success begins early for small molecule drugs
European Pharmaceutical Review
OCTOBER 31, 2022
The race to the first-in-human (FIH) milestone is underscored by the rise in expedited programmes such as Fast Track designation, Accelerated Approval, Priority Review designation and Breakthrough Therapy designation. 1 Within these programmes, the ability to identify and solve challenges in the early stages with agility and flexibility is critical to successful early clinical trials that will help advance drugs from late stage through product launch.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Developing a channel strategy that optimizes gross to net
PharmaVoice
OCTOBER 31, 2022
Today, pharma manufacturers face unprecedented GTN challenges. To unlock sustainable brand growth, a value-aligned channel strategy is pivotal.
Actinium eyes filing as conditioning drug for AML aces trial
pharmaphorum
OCTOBER 31, 2022
Actinium Pharma is on course to submit its targeted radiotherapy for acute myeloid leukaemia (AML) patients needing a bone marrow transplant in the US, buoyed by top-line data from a pivotal trial. The New York biotech said today that the SIERRA trial of Iomab-B – an antibody armed with a radioisotope designed to deliver targeted treatment to tumours and spare healthy tissues – met its primary objective.
Pharmacist Impact on Provider Productivity and Billing: Ambulatory Care Clinic
Pharmacy Times
OCTOBER 31, 2022
Providers working in collaboration with pharmacists saw significantly more patients than providers who worked independently.
Aqemia raises €30m to scale drug discovery platform
Outsourcing Pharma
OCTOBER 31, 2022
The company states that its platform combines quantum-inspired physics and machine learning to accelerate drug discovery.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Case Study: Treating Chronic Hypertension in Pregnancy
Pharmacy Times
OCTOBER 31, 2022
Chronic hypertension during pregnancy increases the risk of poor pregnancy and birth outcomes.
STAT+: Private equity’s Welsh Carson, casting itself as a noble force, relentlessly pursues profits in health care
STAT
OCTOBER 31, 2022
Before the allegations of neglect, before the lawsuits, before the government investigations, the health care nonprofit InnovAge had a simple mission: Help the sickest and poorest seniors live comfortably in their communities, beyond the confines of nursing homes and hospitals. It accomplished this by coordinating care for older Americans in a handful of states under a little-known, taxpayer-funded program.
Camizestrant Shows Improved Survival Benefit Compared to Fulvestrant in Advanced ER-Positive Breast Cancer
Pharmacy Times
OCTOBER 31, 2022
Camizestrant is a next-generation oral SERD and pure Er? antagonist that has demonstrated anti-cancer activity across a range of preclinical models, including in patients with ER-activating mutations.
In a year it was supposed to flare, polio-like syndrome in kids doesn’t, adding to mystery
STAT
OCTOBER 31, 2022
Physicians who treat children who develop a strange polio-like syndrome known as acute flaccid myelitis had been steeling themselves this fall for an onslaught of cases of the irreversible condition, which appears to be triggered by infection with an enterovirus known as EV-D68. Like many respiratory viruses, circulation of EV-D68 appeared to be suppressed by Covid-19 control measures earlier in the pandemic.
5 Key Sessions, Interviews at the American Society of Consultant Pharmacists 2022 Annual Meeting
Pharmacy Times
OCTOBER 31, 2022
Pharmacy Times will be covering the American Society of Consultant Pharmacists (ASCP) Annual Meeting, which will be gathering senior care pharmacists in San Antonio, Texas.
Opinion: Inconsistent clinical practices thwart wider use of personalized medicine
STAT
OCTOBER 31, 2022
The promise of personalized medicine — safer and more effective treatments tailored to each individual’s body and needs — isn’t being fully met because of challenges associated with its implementation in clinical practice. In a special report published today in JCO Precision Oncology, we and our colleagues from Diaceutics, the Personalized Medicine Coalition, and Reservoir Communications provide the first in-depth look at the efforts of United States health systems to
Frito-Lay’s iconic chips take on bite-sized format
Drug Store News
OCTOBER 31, 2022
Minis are bite-sized versions of the company’s Doritos, Cheetos and SunChips snacks that come in an easy-to-pour canister.
STAT+: Pharmalittle: FDA advisers vote down pediatric brain cancer drug; AbbVie drops out of psoriasis partnership
STAT
OCTOBER 31, 2022
Good morning, and welcome to a spooky edition of Pharmalittle. It’s Jason Mast here, filling in for Ed. Nothing too scary on the docket — unless you consider broken partnerships and spurned FDA applications scary — but I have dropped a Reese’s cup in my coffee this morning, which, for bean purists, is probably a little frightful.
EMA validates AbbVie lymphoma bispecific antibody application
European Pharmaceutical Review
OCTOBER 31, 2022
AbbVie has announced that the European Medicines Agency (EMA) has validated its Marketing Authorisation Application (MAA) for epcoritamab, a bispecific antibody (bsAb) for adults with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) after more than two lines of systemic therapy, offering patients a potential new therapy option. Additionally, Danish biotech Genmab has submitted a Biologics License Application (BLA) to the US Food and Drug Administration (FDA) for epcoritamab for ad
Could Colgate-Palmolive be headed for a break up?
Drug Store News
OCTOBER 31, 2022
A Wall Street Journal report notes that an activist challenge to Colgate-Palmolive has stirred a discussion over the possibility of whether and how the consumer giant could ultimately be broken up.
Anthropy 2022
pharmaphorum
OCTOBER 31, 2022
Between the 2nd and 4th November, a veritable who’s who of British industry will gather at the Eden Project in Boldeva, Cornwall for Anthropy 2022, the event’s second year. Over three days and across 12 stages within multiple biomes, over 130 sessions will take place, including 300 speakers. The singular purpose of them all? ‘A Vision for Britain.’.
EMA’s PRAC confirms recommendation to withdraw amfepramones
European Pharmaceutical Review
OCTOBER 31, 2022
The Pharmacovigilance Risk Assessment Committee (PRAC) , the European Medicines Agency (EMA)’s safety board, has confirmed it recommends the withdrawal of Marketing Authorisation Application (MAA) for amfepramone obesity medicines, to prevent more patients being at risk of serious side effects. Risks of amfepramones. The committee observed that patients continued taking the medicines for more than three months, much longer than the recommended four to six weeks.
Kroger Foundation, Thurgood Marshall College Fund announce scholarship recipients
Drug Store News
OCTOBER 31, 2022
Pitch competition winners were awarded $74,000 in scholarships.
STAT+: Advanced practice clinicians slightly more likely to take industry funding than doctors
STAT
OCTOBER 31, 2022
A slightly larger share of nurse practitioners, physician assistants, and other advanced practice clinicians accept payments from drug and device makers compared with physicians, a first-of-its-kind study found. Of all the advanced practice clinicians working in the U.S. in 2021, 36% accepted payments from industry, compared with 35% of physicians, according to new findings released Monday in the Journal of the American Medical Association.
Biopharma successful in achieving climate-related goals, report finds
European Pharmaceutical Review
OCTOBER 31, 2022
EcoAct’s 12th annual Corporate Climate Reporting Performance Report revealed the biopharmaceutical sector was above average in achieving emission-related goals, with GSK being FTSE 100’s best performer. Yet half (52 percent) of FTSE 100 companies were found not to have reduced emissions aligned to a 1.5°C trajectory. Some unfortunately, increased their emissions.
Let's personalize your content